Renalytix Plc (AIM: RENX)
London
· Delayed Price · Currency is GBP · Price in GBX
7.50
0.00 (0.00%)
Oct 11, 2024, 4:10 PM GMT+1
Renalytix Revenue
In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M USD, down -32.74%. Renalytix had revenue of $586.00K in the quarter ending June 30, 2024, with 13.13% growth.
Revenue
$2.29M
Revenue Growth
-32.74%
P/S Ratio
4.48
Revenue / Employee
$22.44K
Employees
102
Market Cap
12.44M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRenalytix News
- 3 months ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 3 months ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire
- 4 months ago - Medicare Issues Final Coverage Determination for kidneyintelX.dkd - GlobeNewsWire
- 5 months ago - Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 5 months ago - Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 - GlobeNewsWire
- 6 months ago - Renalytix Announces Financing with Expected Size of up to $4 Million - GlobeNewsWire
- 7 months ago - KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) - GlobeNewsWire